INOZYME PHARMA INC

CUSIP: 45790W108 Class: Common Stock

ADAGE CAPITAL PARTNERS GP, L.L.C.'s Holding History (CIK: 0001165408)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 5,160,000 Value ($000) $4,696 Avg Close Range
Q4 2024
Shares 5,160,000 Value ($000) $14,293 Avg Close Range
Q3 2024
Shares 5,673,629 Value ($000) $29,673 Avg Close Range
Q2 2024
Shares 5,728,856 Value ($000) $25,551 Avg Close Range
Q1 2024
Shares 5,328,856 Value ($000) $40,819 Avg Close Range
Q4 2023
Shares 5,537,500 Value ($000) $23,590 Avg Close Range
Q3 2023
Shares 5,537,500 Value ($000) $23,258 Avg Close Range
Q2 2023
Shares 4,250,000 Value ($000) $23,673 Avg Close Range
Q1 2023
Shares 4,265,138 Value ($000) $24,439 Avg Close Range
Q4 2022
Shares 3,100,138 Value ($000) $3,255 Avg Close Range
Q3 2022
Shares 2,596,672 Value ($000) $6,959 Avg Close Range
Q2 2022
Shares 2,546,672 Value ($000) $12,148 Avg Close Range
Q1 2022
Shares 1,746,672 Value ($000) $7,144 Avg Close Range
Q4 2021
Shares 1,599,028 Value ($000) $10,905 Avg Close Range
Q3 2021
Shares 1,467,828 Value ($000) $17,012 Avg Close Range
Q2 2021
Shares 1,288,672 Value ($000) $21,959 Avg Close Range
Q1 2021
Shares 1,089,672 Value ($000) $21,576 Avg Close Range
Q4 2020
Shares 896,672 Value ($000) $18,507 Avg Close Range
Q3 2020
Shares 800,000 Value ($000) $21,032 Avg Close Range